clinical trial

By Laura Lovett 11:12 am September 11, 2019
When it comes to clinical trials, oftentimes the majority of a patient’s experience happens “off stage” in their home or community. For example, medication adherence, or nonadherence, has been a major pitfall in medicine. Studies have found that roughly one in five new prescriptions are never filled, and of those filled up to 50% are taken incorrectly.  Startups have taken notice and the digital...
By Dave Muoio 10:47 am July 31, 2019
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data. Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...

Verisense by Shimmer IMU (Photo courtesy Shimmer)

By Jonah Comstock 01:35 pm February 19, 2019
Shimmer, a Dublin-based wearable sensor company, has launched a new sensor platform for clinical trials called VeriSense. At launch, the platform will work with Shimmer's IMU, or inertial measurement unit, sensor, which can measure activity and sleep from the wrist, as well as network with sensors elsewhere on the body to monitor musculoskeletal and neurological conditions. The company has been...
By Laura Lovett 01:03 pm October 9, 2018
Biopharmaceutical service Parexel International Corporation is turning its attention to mobile and wearable technology to aid drug development and clinical research. This morning the Boston-based company announced a slew of new products that will be built on its Perceptive Cloud platform.  One of the new technologies uses Microsoft’s Azure App Services and will be able to send patient data to...
By Jonah Comstock 04:30 pm May 16, 2018
Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system. BioStamp nPoint is a more advanced version of the company's non-FDA cleared BioStampRC. "BiostampRC was primarily developed as an investigational tool, primarily used by academia, as well as by pharmaceutical companies,...
By Laura Lovett 12:23 pm March 8, 2018
The Mayo Clinic has just released the results of a new study, which show an 80 percent increase in enrollment of clinical trials for breast cancer when using IBM’s Watson for Clinical Trial matching system.  The Watson system uses artificial intelligence to analyze unstructured information and pull out insights from the data.  “Watson is able to give us faster, better matching of patients to...
By Heather Mack 02:58 pm January 11, 2017
Cambridge, Massachusetts-based Clinical Research IO, which developed an electronic platform for researchers to quickly capture data during clinical trials, has raised $1.6 million in seed funding in a round led by NXT Ventures and Rally Ventures. Previously, the company raised $800,000, and the latest funding brings the company’s total to $2.4 million. The funding will be used to develop Clinical...
By Jonah Comstock 02:04 pm May 10, 2016
New York City-based ProofPilot, a startup creating technology to help anyone launch a randomized control trial, has re-launched its clinical trial product. The software-as-a-service product is available to academic and clinical researchers as well as individuals, non-profits, and community groups. There are a range of versions at different price points, with the lowest being free and the highest...
By Jonah Comstock 04:09 pm April 13, 2016
Last month, MobiHealthNews published a list of 21 clinical trials currently using a Fitbit activity tracker. That wasn't the whole list, though. In fact, our search turned up so many trials with the Fitbit -- and again, not even including the many other wearable activity trackers on the market -- that we had to split the results into two articles. Read on below for 18 more trials using Fitbit...
By Jonah Comstock 02:19 pm April 11, 2016
AliveCor is continuing to build up the clinical evidence for the efficacy of its smartphone-connected Kardia ECG devices. According to a new posting on ClinicalTrials.gov, AliveCor is gearing up to launch a 300-patient randomized trial at Columbia University to test the effect of technology-enabled remote monitoring on atrial fibrillation. "Atrial fibrillation (AF), a condition where the top...